Deep Track Capital, LP Nkarta, Inc. Transaction History

Deep Track Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$5.14 - $14.35 $7.51 Million - $21 Million	-1,460,644 Reduced 51.89%	1,354,200 $8.11 Million
Q2 2022 Aug 12, 2022	BUY	$7.77 - $19.44 $5.45 Million - $13.6 Million	701,049 Added 33.17%	2,814,844 $34.7 Million
Q1 2022 May 16, 2022	BUY	$8.66 - $14.99 $7.36 Million - $12.7 Million	849,369 Added 67.17%	2,113,795 $24.1 Million
Q4 2021 Feb 14, 2022	BUY	$12.79 - $26.88 $16.2 Million - $34 Million	1,264,426 New	1,264,426 $19.4 Million

129

66.5M

173K

20K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $119M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Deep Track Capital, LP with notifications on news.